Cardona AF - Search Results

1

Impact of KRAS^G12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes.

Caballé-Perez E, Hernández-Pedro N, Ramos-Ramírez M, Barrios-Bernal P, Romero-Núñez E, Lucio-Lozada J, Ávila-Ríos S, Reyes-Terán G, Cardona AF, Arrieta O. Caballé-Perez E, et al. Among authors: cardona af. Clin Transl Oncol. 2024 Apr;26(4):836-850. doi: 10.1007/s12094-023-03279-2. Epub 2023 Jul 25. Clin Transl Oncol. 2024. PMID: 37490263 Free PMC article.

2

Clinical and pathological characteristics, outcome and mutational profiles regarding non-small-cell lung cancer related to wood-smoke exposure.

Arrieta O, Campos-Parra AD, Zuloaga C, Avilés A, Sánchez-Reyes R, Manríquez ME, Covián-Molina E, Martínez-Barrera L, Meneses A, Cardona A, Borbolla-Escoboza JR. Arrieta O, et al. J Thorac Oncol. 2012 Aug;7(8):1228-34. doi: 10.1097/JTO.0b013e3182582a93. J Thorac Oncol. 2012. PMID: 22659961 Free article.

3

KRAS mutation as the biomarker of response to chemotherapy and EGFR-TKIs in patients with advanced non-small cell lung cancer: clues for its potential use in second-line therapy decision making.

Campos-Parra AD, Zuloaga C, Manríquez ME, Avilés A, Borbolla-Escoboza J, Cardona A, Meneses A, Arrieta O. Campos-Parra AD, et al. Am J Clin Oncol. 2015 Feb;38(1):33-40. doi: 10.1097/COC.0b013e318287bb23. Am J Clin Oncol. 2015. PMID: 23538866

4

Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP).

Arrieta O, Cardona AF, Martín C, Más-López L, Corrales-Rodríguez L, Bramuglia G, Castillo-Fernandez O, Meyerson M, Amieva-Rivera E, Campos-Parra AD, Carranza H, Gómez de la Torre JC, Powazniak Y, Aldaco-Sarvide F, Vargas C, Trigo M, Magallanes-Maciel M, Otero J, Sánchez-Reyes R, Cuello M. Arrieta O, et al. Among authors: cardona af. J Thorac Oncol. 2015 May;10(5):838-843. doi: 10.1097/JTO.0000000000000481. J Thorac Oncol. 2015. PMID: 25634006 Free article.

5

Epithelial-mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy.

Rojas-Puentes L, Cardona AF, Carranza H, Vargas C, Jaramillo LF, Zea D, Cetina L, Wills B, Ruiz-Garcia E, Arrieta O. Rojas-Puentes L, et al. Among authors: cardona af. Cancer Med. 2016 Aug;5(8):1989-99. doi: 10.1002/cam4.751. Epub 2016 May 27. Cancer Med. 2016. PMID: 27230280 Free PMC article.

6

Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America.

Raez LE, Santos ES, Rolfo C, Lopes G, Barrios C, Cardona A, Mas LA, Arrieta O, Richardet E, Vallejos S C, Wistuba I, Gandara D, Hirsch FR. Raez LE, et al. Clin Lung Cancer. 2017 Jan;18(1):e71-e79. doi: 10.1016/j.cllc.2016.05.003. Epub 2016 Jun 5. Clin Lung Cancer. 2017. PMID: 27426974 Review.

7

Survival of Patients with Advanced Non-Small Cell Lung Cancer Enrolled in Clinical Trials.

Arrieta O, Carmona A, Ramírez-Tirado LA, Flores-Estrada D, Macedo-Pérez EO, Martínez-Hernández JN, Corona-Cruz JF, Cardona AF, de la Garza J. Arrieta O, et al. Among authors: cardona af. Oncology. 2016;91(4):185-193. doi: 10.1159/000447404. Epub 2016 Jul 23. Oncology. 2016. PMID: 27449344

8

Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer.

Arrieta O, Varela-Santoyo E, Soto-Perez-de-Celis E, Sánchez-Reyes R, De la Torre-Vallejo M, Muñiz-Hernández S, Cardona AF. Arrieta O, et al. Among authors: cardona af. BMC Cancer. 2016 Aug 12;16:633. doi: 10.1186/s12885-016-2658-6. BMC Cancer. 2016. PMID: 27519177 Free PMC article.

9

The safety of afatinib for the treatment of non-small cell lung cancer.

Barron F, de la Torre-Vallejo M, Luna-Palencia RL, Cardona AF, Arrieta O. Barron F, et al. Among authors: cardona af. Expert Opin Drug Saf. 2016 Nov;15(11):1563-1572. doi: 10.1080/14740338.2016.1236910. Epub 2016 Sep 28. Expert Opin Drug Saf. 2016. PMID: 27633264 Review.

10

Skin communicates what we deeply feel: antibiotic prophylactic treatment to reduce epidermal growth factor receptor inhibitors induced rash in lung cancer (the Pan Canadian rash trial).

Arrieta O, Carmona A, de Jesus Vega MT, Lopez-Mejia M, Cardona AF. Arrieta O, et al. Among authors: cardona af. Ann Transl Med. 2016 Aug;4(16):313. doi: 10.21037/atm.2016.08.19. Ann Transl Med. 2016. PMID: 27668233 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

213 results

Search Page